Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Sean Bohen
Marketing
AZ, Merck's Lynparza scores data worth a shot at $1B boost
AstraZeneca and Merck are eyeing a $1 billion boost for Lynparza, thanks to a trial win for women who have just been diagnosed with ovarian cancer.
Tracy Staton
Jun 27, 2018 10:08am
AstraZeneca revs up for quick FDA review on new Lynparza use
Mar 28, 2017 10:55am
AZ's Lynparza fends off ovarian cancer
Mar 14, 2017 3:33pm
